• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性肺纤维化的全球发病率和死亡率:系统评价。

Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review.

机构信息

Division of Epidemiology and Public Health, School of Medicine, University of Nottingham, Nottingham, UK

Division of Epidemiology and Public Health, School of Medicine, University of Nottingham, Nottingham, UK.

出版信息

Eur Respir J. 2015 Sep;46(3):795-806. doi: 10.1183/09031936.00185114. Epub 2015 May 14.

DOI:10.1183/09031936.00185114
PMID:25976683
Abstract

As idiopathic pulmonary fibrosis emerges as an important public health problem, there is a need to coordinate data on incidence and mortality globally. This study aims to systematically assess all available studies to investigate the global burden of disease.Medline and Embase databases were searched systematically for all population-based studies of incidence or mortality of idiopathic pulmonary fibrosis. Clinical case series and prevalence studies were excluded. The search was supplemented using the Google search engine, hand-searching of references and conference abstracts. Data were extracted independently by two authors using a pre-specified proforma, with assessment of methodological quality.34 studies were identified, providing data from 21 countries from 1968-2012. 28 studies reported incidence data and eight reported mortality data. In studies from the year 2000 onwards, we estimated a conservative incidence range of 3-9 cases per 100 000 per year for Europe and North America. Incidence was lower in East Asia and South America. The majority of studies showed an increase in incidence over time.The incidence of idiopathic pulmonary fibrosis is increasing worldwide and rates are coming together across countries. Current data suggest incidence is similar to that of conditions such as stomach, liver, testicular and cervical cancers.

摘要

特发性肺纤维化作为一个重要的公共卫生问题出现,因此有必要在全球范围内协调发病率和死亡率的数据。本研究旨在系统评估所有现有的研究,以调查全球疾病负担。系统地检索了 Medline 和 Embase 数据库中所有基于人群的特发性肺纤维化发病率或死亡率的研究。排除了临床病例系列和流行率研究。使用 Google 搜索引擎、参考文献和会议摘要的手工搜索对搜索进行了补充。两位作者使用预先指定的方案独立提取数据,并对方法学质量进行评估。确定了 34 项研究,提供了来自 1968 年至 2012 年的 21 个国家的数据。28 项研究报告了发病率数据,8 项研究报告了死亡率数据。在 2000 年以后的研究中,我们估计欧洲和北美的保守发病率范围为每年每 10 万人 3-9 例。东亚和南美洲的发病率较低。大多数研究表明发病率随时间增加。特发性肺纤维化的发病率在全球范围内正在增加,并且各国的发病率正在趋同。目前的数据表明,发病率与胃癌、肝癌、睾丸癌和宫颈癌等疾病的发病率相似。

相似文献

1
Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review.特发性肺纤维化的全球发病率和死亡率:系统评价。
Eur Respir J. 2015 Sep;46(3):795-806. doi: 10.1183/09031936.00185114. Epub 2015 May 14.
2
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
3
Sex as a prognostic factor for mortality in adults with acute symptomatic pulmonary embolism.性别作为急性症状性肺栓塞成年患者死亡率的一个预后因素。
Cochrane Database Syst Rev. 2025 Mar 20;3(3):CD013835. doi: 10.1002/14651858.CD013835.pub2.
4
Inhaled mannitol for cystic fibrosis.吸入用甘露醇治疗囊性纤维化。
Cochrane Database Syst Rev. 2015 Oct 9(10):CD008649. doi: 10.1002/14651858.CD008649.pub2.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
6
Population-based biomedical sexually transmitted infection control interventions for reducing HIV infection.基于人群的生物医学性传播感染控制干预措施以减少艾滋病毒感染。
Cochrane Database Syst Rev. 2011 Mar 16(3):CD001220. doi: 10.1002/14651858.CD001220.pub3.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
8
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
9
SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.用于治疗 COVID-19 的 SARS-CoV-2 中和单克隆抗体。
Cochrane Database Syst Rev. 2021 Sep 2;9(9):CD013825. doi: 10.1002/14651858.CD013825.pub2.
10
Direct-acting antivirals for chronic hepatitis C.用于慢性丙型肝炎的直接作用抗病毒药物。
Cochrane Database Syst Rev. 2017 Sep 18;9(9):CD012143. doi: 10.1002/14651858.CD012143.pub3.

引用本文的文献

1
Targeting E3 ubiquitin ligases: a new frontier in idiopathic pulmonary fibrosis treatment.靶向E3泛素连接酶:特发性肺纤维化治疗的新前沿。
Front Immunol. 2025 Aug 18;16:1618424. doi: 10.3389/fimmu.2025.1618424. eCollection 2025.
2
Pathophysiological Insights and Clinical Management Strategies for Interstitial Lung Diseases.间质性肺疾病的病理生理见解与临床管理策略
Biomol Ther (Seoul). 2025 Sep 1;33(5):785-803. doi: 10.4062/biomolther.2025.003. Epub 2025 Aug 14.
3
Mendelian randomization revealed a one-way causal association between increased Isovalerylcarnitine (C5) levels and the risk of idiopathic pulmonary fibrosis.
孟德尔随机化研究揭示了异戊酰肉碱(C5)水平升高与特发性肺纤维化风险之间的单向因果关联。
Medicine (Baltimore). 2025 Aug 8;104(32):e43555. doi: 10.1097/MD.0000000000043555.
4
Endogenous gene editing of alveolar organoids reveals that expression of pathogenic variant SFTPC-I73T disrupts endosomal function, epithelial polarity and wound healing.肺泡类器官的内源性基因编辑表明,致病性变体SFTPC-I73T的表达会破坏内体功能、上皮极性和伤口愈合。
bioRxiv. 2025 Jul 22:2025.07.22.665497. doi: 10.1101/2025.07.22.665497.
5
Incidence and prevalence of idiopathic pulmonary fibrosis: a systematic literature review and meta-analysis.特发性肺纤维化的发病率和患病率:一项系统文献综述与荟萃分析。
BMC Pulm Med. 2025 Aug 7;25(1):378. doi: 10.1186/s12890-025-03836-1.
6
Pirfenidone combined with UC-MSCs reversed bleomycin-induced pulmonary fibrosis.吡非尼酮联合脐带间充质干细胞可逆转博来霉素诱导的肺纤维化。
Sci Rep. 2025 Aug 4;15(1):28339. doi: 10.1038/s41598-025-14286-4.
7
The mechanism of plasma exosome miR-15a-5p targeting the CF-modified protein IGF1R to regulate alveolar epithelial autophagy and influence pulmonary interstitial fibrosis.血浆外泌体miR-15a-5p靶向CF修饰蛋白IGF1R调控肺泡上皮自噬并影响肺间质纤维化的机制
Noncoding RNA Res. 2025 Jul 3;15:51-64. doi: 10.1016/j.ncrna.2025.07.001. eCollection 2025 Dec.
8
MUC5B Polymorphism and Susceptibility to Idiopathic Pulmonary Fibrosis in Morocco.摩洛哥人群中MUC5B基因多态性与特发性肺纤维化易感性的关系
Cureus. 2025 Jun 26;17(6):e86806. doi: 10.7759/cureus.86806. eCollection 2025 Jun.
9
An Overview of the Role of Genetic factors in Idiopathic Pulmonary Fibrosis: Insights from Epidemiology to Prognosis.遗传因素在特发性肺纤维化中的作用概述:从流行病学到预后的见解
Int J Med Sci. 2025 Jun 12;22(12):2992-3006. doi: 10.7150/ijms.113226. eCollection 2025.
10
Investigation into the protective effects of protocatechuic acid in bleomycin-induced pulmonary remodeling and fibrosis in rats: role of MMP-2/TIMP-1 and CTGF/NOX4 pathway.原儿茶酸对博来霉素诱导的大鼠肺重塑和纤维化的保护作用研究:MMP-2/TIMP-1和CTGF/NOX4通路的作用
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jul 10. doi: 10.1007/s00210-025-04410-6.